These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 29230043)

  • 1. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression.
    Pi F; Binzel DW; Lee TJ; Li Z; Sun M; Rychahou P; Li H; Haque F; Wang S; Croce CM; Guo B; Evers BM; Guo P
    Nat Nanotechnol; 2018 Jan; 13(1):82-89. PubMed ID: 29230043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
    Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
    ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer.
    Liu HY; Yu X; Liu H; Wu D; She JX
    Sci Rep; 2016 Jul; 6():30346. PubMed ID: 27456457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice.
    Yang J; Xie SX; Huang Y; Ling M; Liu J; Ran Y; Wang Y; Thrasher JB; Berkland C; Li B
    Nanomedicine (Lond); 2012 Sep; 7(9):1297-309. PubMed ID: 22583574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer.
    Wang Y; Chen X; Tian B; Liu J; Yang L; Zeng L; Chen T; Hong A; Wang X
    Theranostics; 2017; 7(5):1360-1372. PubMed ID: 28435471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
    Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
    J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
    Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
    Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Small-Cell Lung Cancer Regression by siRNA Delivered Through Exosomes That Display EGFR RNA Aptamer.
    Li Z; Yang L; Wang H; Binzel DW; Williams TM; Guo P
    Nucleic Acid Ther; 2021 Oct; 31(5):364-374. PubMed ID: 33999716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of the therapeutic dose of silencing RNA by packaging it in extracellular vesicles via a pre-microRNA backbone.
    Reshke R; Taylor JA; Savard A; Guo H; Rhym LH; Kowalski PS; Trung MT; Campbell C; Little W; Anderson DG; Gibbings D
    Nat Biomed Eng; 2020 Jan; 4(1):52-68. PubMed ID: 31937944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
    Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
    Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.
    O'Loughlin AJ; Mäger I; de Jong OG; Varela MA; Schiffelers RM; El Andaloussi S; Wood MJA; Vader P
    Mol Ther; 2017 Jul; 25(7):1580-1587. PubMed ID: 28392161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small extracellular vesicle-mediated
    Krishn SR; Garcia V; Naranjo NM; Quaglia F; Shields CD; Harris MA; Kossenkov AV; Liu Q; Corey E; Altieri DC; Languino LR
    Cancer Biol Ther; 2022 Dec; 23(1):173-185. PubMed ID: 35188070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered extracellular vesicles with synthetic lipids via membrane fusion to establish efficient gene delivery.
    Jhan YY; Prasca-Chamorro D; Palou Zuniga G; Moore DM; Arun Kumar S; Gaharwar AK; Bishop CJ
    Int J Pharm; 2020 Jan; 573():118802. PubMed ID: 31715354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.
    Bae YJ; Yoon YI; Yoon TJ; Lee HJ
    Korean J Radiol; 2016; 17(4):497-508. PubMed ID: 27390541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo.
    Hao Z; Fan W; Hao J; Wu X; Zeng GQ; Zhang LJ; Nie SF; Wang XD
    Drug Deliv; 2016; 23(3):874-81. PubMed ID: 24892627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-Aptamer Coassembly Nanocarrier for Cancer Therapy.
    Ma Y; Li W; Zhou Z; Qin X; Wang D; Gao Y; Yu Z; Yin F; Li Z
    Bioconjug Chem; 2019 Mar; 30(3):536-540. PubMed ID: 30702869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth.
    Su Y; Yu L; Liu N; Guo Z; Wang G; Zheng J; Wei M; Wang H; Yang AG; Qin W; Wen W
    Cancer Lett; 2013 Sep; 338(2):282-91. PubMed ID: 23752065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-enabled, image-guided treatment planning of target specific RNAi therapeutics in an orthotopic prostate cancer model.
    Lin Q; Jin CS; Huang H; Ding L; Zhang Z; Chen J; Zheng G
    Small; 2014 Aug; 10(15):3072-82. PubMed ID: 24706435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.